These findings lay a groundwork for future research to explore the specific causal pathways and develop targeted therapeutic interventions
Over the course of a 2-day workshop in Bethesda, Maryland, this week, RECOVER representatives detailed plans to launch clinical trials for several interventions
Product Features: Laboratory-grade purified water with 0.9% benzyl alcohol Sterilised and filled under controlled conditions Sealed glass vial with tamper-evident crimp cap Multi-use format when handled using appropriate laboratory practices Approximate in-use period of up to 28 days after first opening (subject to controlled handling and storage) Intended Use: Suitable for general laboratory applications, including: Preparation or dilution of non-therapeutic compounds Use in analytical or research procedures requiring sterile conditions Applications where inhibition of microbial growth is essential within a laboratory setting Important Information: Not for human or animal use Not for injection or parenteral administration Not for therapeutic, diagnostic, or clinical purposes Not supplied as a medicine, medical device, or therapeutic good Handling & Storage: Use only with appropriate laboratory procedures
This allowed the drug to bind with albumin, a natural blood protein, creating a protective shield that prevented breakdown by the kidneys and kept it circulating in the body for longer
Microdosing involves using an injection pen or taking a low-dose pill to deliver smaller doses than those indicated on a prescription
PMID 12089231
